Skip to main content

and
  1. No Access

    Article

    Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program

    Metastatic cancers impose significant burdens on patients, affecting quality of life, morbidity, and mortality. Even during remission, microscopic metastases can lurk, but few therapies directly target tumor c...

    Jill M. Pulley, Rebecca N. Jerome, Martin L. Ogletree in Targeted Oncology (2018)